bca101,pembrolizumab
bicara,merck
['bca101', 'head and neck', 'hanna', 'bicara']
persuasive data from dr glenn hanna on bca101, bicara's egfr+tgf-beta bispecific, in head and neck cancer. #asco23 
Pharma and biotech reporter, found a home at Evaluate Vantage.